5-ALPHA REDUCTASE INHIBITORS FOR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA DOES NOT INCREASE THE RISK OF ERECTILE DYSFUNCTION

被引：0
|
作者：
Hagberg, Katrina
Divan, Hozefa
Persson, Rebecca
Jick, Susan
Nickel, J. Curtis
机构：
来源：
JOURNAL OF UROLOGY | 2017年 / 197卷 / 04期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/j.juro.2017.02.325
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP09-17
引用
收藏
页码：E106 / E107
页数：2
相关论文
共 50 条
  • [21] Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
    Fang, Qinghua
    Chen, Peiya
    Du, Ningchao
    Nandakumar, Kutty Selva
    CLINICAL BREAST CANCER, 2019, 19 (05) : E624 - E636
  • [22] 5-alpha Reductase Inhibitors and Prostate Cancer Incidence and Mortality among Men with Benign Prostatic Hyperplasia
    Bhaskaran, Krishnan
    Douglas, Ian
    Smeeth, Liam
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 479 - 479
  • [23] Re: The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs)
    Ayodele, O.
    Cabral, H. J.
    McManus, D.
    Jick, S.
    JOURNAL OF UROLOGY, 2022, 207 (01): : 202 - 202
  • [24] Green light laser efficacy in patients with prostatic hyperplasia treatment with 5-alpha reductase inhibitors
    Juan Escudero, Joaquin Ulises
    Lopez Alcina, Emilio
    Ramos de Campos, Macarena
    Ramada Benlloch, Francisco
    Sanchez Ballester, Francisco
    Marques Vidal, Emilio
    ACTAS UROLOGICAS ESPANOLAS, 2009, 33 (09): : 988 - 993
  • [25] ALPHA BLOCKERS, 5-ALPHA REDUCTASE INHIBITORS, PDE-5 INHIBITORS AND ANTIMUSCARINIC MEDICATION USE IN US PATIENTS DIAGNOSED WITH BENIGN PROSTATIC HYPERPLASIA, AND LOWER URINARY TRACT SYMPTOMS WITH AND WITHOUT ERECTILE DYSFUNCTION
    Burge, R.
    Le, T. K.
    Viktrup, L.
    Watts, S.
    VALUE IN HEALTH, 2011, 14 (07) : A407 - A407
  • [26] 5-Alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasia
    Joseph, Diya B.
    Henry, Gervaise H.
    Malewska, Alicia
    Reese, Jeffrey C.
    Mauck, Ryan J.
    Gahan, Jeffrey C.
    Hutchinson, Ryan C.
    Mohler, James L.
    Roehrborn, Claus G.
    Strand, Douglas W.
    JOURNAL OF PATHOLOGY, 2022, 256 (04): : 427 - 441
  • [27] Clinical Effects of Discontinuing 5-Alpha Reductase Inhibitor in Patients With Benign Prostatic Hyperplasia
    Kim, Won
    Jung, Jae Hung
    Kang, Tae Wook
    Song, Jae Mann
    Chung, Hyun Chul
    KOREAN JOURNAL OF UROLOGY, 2014, 55 (01) : 52 - 56
  • [28] THE RISK OF FRACTURES WITH ALPHA BLOCKERS AND 5-ALPHA REDUCTASE INHIBITORS IN BENIGN PROSTATE HYPERPLASIA: A META-ANALYSIS
    Lim, S.
    Laengvejkal, P.
    Nugent, K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (02) : 457 - 457
  • [29] SILDENAFIL MAY REVERSE ERECTILE DYSFUNCTION CAUSED BY 5-ALPHA REDUCTASE INHIBITORS
    Pinsky, Michael
    Serefoglu, Ege Can
    Gur, Serap
    Sikka, Suresh C.
    Tracey, Anthony
    Harbin, Andrew
    Hellstrom, Wayne J. G.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 13 - 13
  • [30] The Risk of Cardiovascular Disease in Patients With Benign Prostate Hyperplasia on 5-Alpha Reductase Inhibitors Treatment: A Meta-Analysis
    Pramana, Ketut Angga Aditya Putra
    Sauqy, Akhmad Sandy
    Pintaningrum, Yusra
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (16) : S55 - S55
12345